SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-17-000152
Filing Date
2017-02-21
Accepted
2017-02-21 07:25:35
Documents
2
Group Members
DRAGON ALPHA LPLANCHU LIU

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss31368_sc13da.htm SC 13D/A 89115
2 NOTICE OF TERMINATION OF CONSORTIUM AGREEMENT ss31368_ex9904.htm EX-99.4 11628
  Complete submission text file 0000947871-17-000152.txt   102353
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 17623464
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4F HARBOUR PLACE, 103 SOUTH CHURCH ST POST OFFICE BOX 10240 GRAND CAYMAN E9 KYI-1002
Business Address 4F HARBOUR PLACE, 103 SOUTH CHURCH ST POST OFFICE BOX 10240 GRAND CAYMAN E9 KYI-1002 86.10.6410.5322
Jade Park Investments Ltd (Filed by) CIK: 0001667315 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A